BioSpace News Archive

Lavie Bio Ltd. today announced it had received registration for Thrivus™ from The Canadian Food Inspection Agency (CFIA).

EDETEK Inc. is excited to announce today that one of the world’s largest pharmaceutical companies enrolled 400 clinical trials into CONFORM™ Informatics.

PureTech Health plc today announced that Eric Elenko, Ph.D., Chief Innovation Officer, and Julie Krop, M.D., Chief Medical Officer, will participate in a fireside chat at the Jefferies Healthcare Conference on Wednesday, June 7th, 2023.

Mind Medicine announced today the upcoming presentation of preclinical data of MM-402, the Company’s proprietary form of the R-enantiomer of 3,4-Methylenedioxymethamphetamine (“MDMA”).

Appili Therapeutics Inc. today announced that the United States Patent and Trademark Office (“USPTO”) has published patent claims for ATI-1501 under the U.S. Application No. 18/072,154 filed on November 30, 2022 and titled “ Oral Formulations of Metronidazole and Methods of Treating an Infection Using Same”.

Relmada Therapeutics, Inc. today announced that clinical data related to REL-1017, the company’s lead product candidate, will be presented in-person in two late-breaking poster presentations at the American Society of Clinical Psychopharmacology 2023 Annual Meeting.

Cybin Inc. today announced that the first participants have been dosed with CYB004 in its ongoing three-part Phase 1 clinical trial evaluating intravenous N,N-dimethyltryptamine (“IV DMT”) and CYB004 in healthy volunteers.

MBX Biosciences, Inc. announced that Kent Hawryluk, President and Chief Executive Officer, will present at the Jefferies Healthcare Conference on Thursday, June 8th, 2023, at 2:30 p.m. Eastern Time and will host 1-on-1 investor meetings.

GeoVax Labs, Inc. (Nasdaq: GOVX) announced today the presentation of updates on the development of its next-generation SARS-CoV-2 vaccine, GEO-CM04S1, including preliminary data from an ongoing Phase 2 clinical trial, during the Vaccines Summit Boston 2023 and the Congress for the International Society for the Advancement of Cytometry (CYTO) 2023 meetings.

Nautilus Biotechnology, Inc. today announced the company will be participating in the following investor conferences.